Related Experiment Videos
[Interactions between cytostatic agents and other drugs].
R Henriksson1, P Bergström, K Grankvist
1Inst för onkologi och klinisk kemi, Umeå universitetssjukhus.
Nordisk Medicin
|January 1, 1990
Summary
Drug interactions involving anticancer drugs can be dangerous due to their narrow therapeutic index. This review examines interactions between anticancer agents and other drugs, focusing on tumor effects and toxicity.
Area of Science:
- Oncology
- Pharmacology
- Clinical Pharmacy
Context:
- Increasing complexity of clinical practice with new drug approvals.
- Rising life expectancy leading to polypharmacy in patients.
- Cytotoxic drugs possess a narrow therapeutic index, necessitating careful dosing.
Purpose:
- To review drug interactions involving anticancer agents.
- To analyze effects on tumor response and patient toxicity.
- To highlight interactions with other clinically used pharmaceuticals.
Summary:
- Drug interactions are common and can significantly alter the efficacy and toxicity of treatments.
- Anticancer drugs, due to their narrow therapeutic index, are particularly susceptible to adverse effects from interactions.
- While interactions between cancer treatment modalities are studied, those with other drugs are less explored.
Impact:
- Provides a comprehensive overview of anticancer drug interactions.
- Informs clinical practice regarding potential drug-drug interactions in cancer patients.
- Aims to improve patient safety and therapeutic outcomes by understanding interaction profiles.